Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review
In Brief: Painter Is AMA President-Elect; FDA Approves Taxol; Protocol Enrolls 150-200 A Month
FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate
FDA Officials Lists ‘Lessons’ Learned Working With AIDS Patient Organizations
FDA Lacks Resources To Deal With Onslaught Of New Cancer Drugs, Friedman Tells Agency
Trending Stories
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - CBER Director Vinay Prasad sidelined staff to jettison Moderna’s mRNA flu shot
- After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored









